Alexandria Real Estate Equities which can be found using ticker (ARE) now have 10 analysts in total covering the stock. The consensus rating is pointing to ‘Buy’. The target price High/Low ranges between 198 and 140 and has a mean target at $173.60. Given that the stocks previous close was at $123.83 this indicates there is a potential upside of 40.2%. The day 50 moving average is $135.13 and the 200 day MA is $146.59. The total market capitalization for the company now stands at $21,530m. You can visit the company’s website by visiting: https://www.are.com
The potential market cap would be $30,183m based on the market consensus.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since its founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and technology campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The trusted partner to approximately 1,000 tenants, Alexandria has a total market capitalization of $35.0 billion and an asset base in North America of 74.6 million square feet (“SF”) as of December 31, 2022, which includes 41.8 million RSF of operating properties and 5.6 million RSF of Class A properties undergoing construction, 9.9 million RSF of near-term and intermediate-term development and redevelopment projects, and 17.3 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A properties clustered in life science, agtech, and technology campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agrifoodtech, climate innovation, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
The company has a dividend yield of 3.89% with the ex dividend date set at 30-3-2023 (DMY).
Other points of data to note are a P/E ratio of 39.01, revenue per share of 16.02 and a 1.19% return on assets.
